Immunochemotherapy: Clinical Trials

6 trials of Immunochemotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 2 recruiting, 1 completed, 1 unknown. 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 26Not yet recruiting 2, Recruiting 2, Completed 1, Unknown 1

Follow Immunochemotherapy: new trials by email Literature Review of Immunochemotherapy trials Research Report on Immunochemotherapy

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Primary Tumor Resection With Sintilimab and Chemotherapy in Advanced NSCLC
Cytoreductive surgery, Immunochemotherapy - Non Small Cell Lung Cancer
Phase 2Not yet recruitingJianxing He1182025-09-102025-09-16
Neoadjuvant/Adjuvant Tislelizumab Combined With Anlotinib and Platinum Doublet Chemotherapy With Resectable NSCLC
Immunochemotherapy combined with antiangiogenic, Immunochemotherapy - Non-Small Cell Lung Cancer, Anti Angiogenesis
Phase 2Not yet recruitingTang-Du Hospital1782024-06-302024-06-26
Sintilimab, Pegaspargase Plus GemOx for Untreated Extranodal NK/T-Cell Lymphoma
Immunochemotherapy - Extranodal NK/T-cell Lymphoma
Phase 2RecruitingPeking Union Medical College Hospital492024-05-202025-02-13
Neoadjuvant SBRT in Localized Advanced HNSCC
SBRT+immunochemotherpy, Immunochemotherapy, cetuximab+immunochemotharpy - Head and Neck Squamous Carcinoma
Phase 2RecruitingJiang Feng812023-10-012024-03-12
Nordic Study in Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma
Immunochemotherapy - Central Nervous System Lymphoma
Phase 2CompletedUniversity of Aarhus662007-05-012022-08-04
Prospective Trial on Immunochemotherapy Plus Autologous Stem Cell Transplantation (SCT) and Allogenic SCT in Primary Mantle-Cell-Lymphoma
Immunochemotherapy, High-dose BEAM plus autologous SCT, HLA-identical allogenic SCT - Mantle-Cell Lymphoma
Phase 2UnknownHeidelberg University202004-07-012009-07-27

Conditions studied

Carcinoma, Non-Small-Cell Lung (2)  ·  Lymphoma, Extranodal NK-T-Cell (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Lymphoma, Non-Hodgkin (1)

Sponsors

Heidelberg University (1)  ·  Jiang Feng (1)  ·  Jianxing He (1)  ·  Peking Union Medical College Hospital (1)  ·  Tang-Du Hospital (1)  ·  University of Aarhus (1)

Countries

China (3)  ·  Denmark (1)  ·  Germany (1)

Top investigators

Anthony D. Ho, Ph.D., Prof. (1)  ·  Linna Liu (1)

Results publications

PMID 25480497